Skip to content
Screener

EyePoint, Inc. EYPT Personnel Expense Including Stock Based Compensation

Personnel Expense Including Stock Based Compensation at other companies

TripAdvisor logo
TripAdvisorTRIP
$37.1M-7.7%
Alto Neuroscience logo
Alto NeuroscienceANRO
$6.25M+8.1%
Claritev Corporation logo
Claritev CorporationCTEV
$51.36M+7.3%
FTC Solar logo
FTC SolarFTCI
$2.52M+2.4%
FTC Solar logo
FTC SolarFTCI
$2.52M+2.4%
Sionna Therapeutics logo
Sionna TherapeuticsSION
$3.87M+73.2%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.03B+41.1%
Enterprise value$938.96M+38.0%
P/S368.3×+354×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept eypt:PersonnelExpenseIncludingStockBasedCompensation.

The source filing: EyePoint, Inc.’s 10-K, filed March 5, 2026.

Filed
Mar 5, 2026, 4:06 PM EST
Fiscal year
FY2025
Accession
0001193125-26-093917
Line itemDecember 31, 2025December 31, 2024
Total revenues$31,371$43,273
DURAVYU direct research and development expense(149,293)(70,818)
Other direct research and development expense(3,036)(2,656)
Personnel expense (including stock based compensation)(83,471)(84,730)
Facilities expense(6,638)(3,921)
Depreciation and amortization(2,309)(1,540)
Intellectual property expense(898)(1,361)
Legal, corporate and professional expenses(12,916)(10,177)

ITEM 16. FORM 10-K SUMMARY

FAQ

What is EyePoint, Inc.'s personnel expense including stock based compensation?
EyePoint, Inc. (EYPT) reported personnel expense including stock based compensation of $20.87M in Q4 2025.
How has EyePoint, Inc.'s personnel expense including stock based compensation changed year-over-year?
EyePoint, Inc.'s personnel expense including stock based compensation decreased by 1.5% year-over-year, from $21.18M to $20.87M.
What is the long-term trend for EyePoint, Inc.'s personnel expense including stock based compensation?
Over 2 years (2023 to 2025), EyePoint, Inc.'s personnel expense including stock based compensation has grown at a 21.3% compound annual growth rate (CAGR), from $56.7M to $83.47M.
What does personnel expense including stock based compensation mean?
Personnel Expense Including Stock Based Compensation as reported by EyePoint, Inc. Common Stock.

Ask your AI about EyePoint, Inc.'s personnel expense including stock based compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude